Curex

Curex is an American telehealth company specializing in immunology, specifically the diagnosis and treatment of allergies, including the prescription and delivery of allergy immunotherapy. The company was founded by Gene Kakaulin and Charles Jacoby in 2020 and is headquartered in New York City. Curex offers a virtual platform that connects patients with doctors for allergy care.

Overview
Founded in 2020 by Gene Kakaulin and Charles Jacoby, the idea for Curex was inspired by the founders’ experiences with allergy shots and allergies. Their experiences lead them to establish Curex, a telemedicine platform dedicated to allergy care.

Curex’s operations encompass a nationwide network of allergy physicians and nurse practitioners. Curex also incorporates a mail-order pharmacy service that delivers allergy immunotherapy and other prescribed medications to patients’ homes.

The company’s primary focus is on treating common environmental allergies, including tree, weed, and grass pollen allergies; dog, cat, and other pet allergies; and indoor allergies such as those caused by mold and dust mites. Curex also treats patients with asthma and atopic dermatitis (eczema), two conditions related to allergies.

Curex provides allergy diagnosis services and facilitates IgE allergy testing with ImmunoCAP, an FDA-cleared technology, which requires a blood draw at home by a phlebotomist or in a lab. Additionally, Curex offers IgE blood testing using self-administered, CLIA-certified test kits.

Curex has established agreements with major insurance providers such as Aetna, Blue Cross Blue Shield, Anthem, United, and Humana.

Chet Tharpe serves as the company’s medical director.

Curex’s providers generally order allergy tests only to detect indoor and outdoor allergens, not food allergens.

After diagnosis, Curex doctors prescribe personalized treatment plans. Treatment plans may include immunotherapy treatments such as sublingual allergy drops or tablets or allergy shots administered at a doctor’s office.

Curex generally sends a three-month supply of immunotherapy treatments to patients to start. Curex doctors continually monitor and adjust treatments as necessary.